Robert H. Bartlett, a pioneering biomedical engineer whose invention of extracorporeal membrane oxygenation (ECMO) has saved countless lives worldwide, died on Tuesday at the age of 86. Bartlett’s groundbreaking system, first used clinically in the early 1970s, provides temporary heart‑ and lung‑support for patients whose organs are failing, buying them critical time for recovery, transplantation, or other definitive therapy.Born in 1939 in Boston, Massachusetts, Bartlett earned a doctorate in biomedical engineering from the Massachusetts Institute of Technology before joining the faculty at the University of Michigan. It was there, in the late 1960s, that he began experimenting with a circuit that could oxygenate blood outside the body while simultaneously removing carbon dioxide—a concept that would later become ECMO.After years of animal studies and painstaking refinement, Bartlett and his team performed the first successful human ECMO run in 1972 on a newborn with severe respiratory distress. The procedure, initially met with skepticism, proved that a mechanical “artificial lung” could sustain a patient for days, weeks, and even months. Over the following decades, ECMO evolved from a niche rescue therapy into a standard of care for neonatal respiratory failure, adult cardiac arrest, and, most recently, severe COVID‑19–related lung injury.“Robert Bartlett didn’t just invent a device; he gave clinicians a lifeline when all other options had been exhausted,” said Dr. Elena Morales, director of the Cardiovascular Research Institute at Stanford University. “His relentless pursuit of safety and efficacy set the benchmark for all subsequent extracorporeal technologies.”Bartlett’s contributions earned him numerous honors, including the National Medal of Technology and Innovation, election to the National Academy of Engineering, and the prestigious Lasker–DeBakey Clinical Medical Research Award. He authored more than 150 peer‑reviewed papers and mentored generations of engineers and physicians who continue to expand the frontiers of extracorporeal support.In the wake of his death, hospitals worldwide have lowered their blinds in tribute, and the International Society for Extracorporeal Technology announced a special session at its upcoming conference to celebrate his legacy. Family members, former colleagues, and patients whose lives were rescued by ECMO have expressed profound gratitude for his lifelong dedication to improving human health.Robert H. Bartlett is survived by his wife of 62 years, Margaret, their three children, and six grandchildren. A private ceremony will be held in Ann Arbor, Michigan, with a public memorial service planned for later in the year. His work, however, will continue to breathe life into patients for generations to come.
Four days after a devastating school collapse in East Java, Indonesia, families of the students are still reeling in shock, grappling with unimaginable grief, and demanding answers. The disaster has left a trail of destruction and heartbreak, with the search for bodies and survivors continuing unabated. As the death toll...
The Northeast's renowned fall foliage season, typically a kaleidoscopic display of reds, oranges, and yellows, has been noticeably muted this year, thanks to a prolonged drought and other environmental factors. The region, particularly New England, usually attracts millions of tourists each autumn to witness the spectacular changing of the leaves....
In a shocking turn of events, Catherine Connolly, a maverick figure in Irish politics, has been elected as the country's President, riding on a wave of anti-establishment sentiment. The landslide victory, which took place last week, saw Connolly garner a landmark popular mandate, marking a significant departure from the traditional...
In a bid to reinvent itself and expand its offerings beyond social networking, Facebook's foray into the world of online dating has unexpectedly turned out to be a major success. The tech giant's free dating service, launched as part of its main platform, has already amassed an impressive 21 million...
In a move that caps a heated contest for promising obesity therapies, Pfizer announced on Monday that it will purchase the U.S. biotech firm Metsera for approximately $10 billion in cash. The agreement puts an end to the bidding war that had seen the Danish pharmaceutical giant Novo Nordisk, the maker of...
A recent cluster of mpox cases in California has raised concerns among health experts, as all three patients, who are residents of the state, have contracted a severe form of the illness without any recent travel history abroad. The cases are attributed to the Clade 1 strain of the virus,...